Hagler Mark Arnold

Insider profile

Performance

Overall performance
0.6

Performance over holding periods
0.6
30 days 90 days 120 days
Average return -26% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Hagler Mark Arnold's trades of NovaBridge Biosciences's stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
383.38
Quantity 13,505 +5.0%
Value US$4,385,312
Transaction date
Purchase
Price
303.09
Quantity 19,710 +19.7%
Value US$745,187
Transaction date
Purchase
Price
12.60
Quantity 33,520 +5.5%
Value US$1,795,634
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-11-19 2026-11-18 B Purchase
13,505 +5.0%
383.38
US$4,385,312
13,505 +5.0% 383.38 US$4,385,312
2026-11-19 2026-11-17 B Purchase
19,710 +19.7%
303.09
US$745,187
19,710 +19.7% 303.09 US$745,187
2026-04-28 2026-04-24 B Purchase
33,520 +5.5%
12.60
US$1,795,634
33,520 +5.5% 12.60 US$1,795,634